Centre Hospitalier Universitaire de Martinique
Fort-de-France, 97261, Martinique
NCT Number: NCT05266313
The paramedic urology team at Martinique University Hospital has developed a "personalized rehabilitation oncosexology program for patients undergoing radical prostatectomy (RP) for localized prostate cancer". The aim of this project is to assess the effectiveness of this program by comparing the sexual quality of life 1 year after surgery between patients participating and those who do not.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
Male
Interventional
Not applicable
Fort-de-France, 97261, Martinique
80% of patients undergoing radical prostatectomy report urinary incontinence and erectile dysfunction [Johanssen et al. 2011. Scandinavian Prostate Cancer Group Study]. In the West Indies, the incidence of prostate cancer is one of the highest in the world (World-standardized incidence in Martinique is 164.5 versus 88.8 per 100,000 person-years in Metropolitan France). Over 2007-2014 an average 530 new cases of prostate cancer were diagnosed each year in Martinique, representing 55% of all male cancers [Regional estimates report Public Health France, January 2018]. The prostate is a symbol of male vulnerability [French Association of Urology-Global Market Research and Public Opinion Specialist, 2006]. For other authors, virility is above all a cultural representation, and the "crisis of virility", a recomposition of male identity. Surgery on a sexual organ can alter body image and masculinity. According to Colson et al., patients treated for prostate cancer and their partners clearly place sex in first place in the importance of quality of life domains.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Thematic workshops throughout the year
Time frame: Before the radical prostatectomy
Administration of sexual of life questionnaire (SEAR for self-esteem and couple relationship)
Time frame: Before the radical prostatectomy
Administration of sexual function questionnaire (IIEF-type validated questionnaires)
Time frame: 1 Month after the radical prostatectomy
Administration of sexual of life questionnaire (SEAR for self-esteem and couple relationship)
Time frame: 1 Month after the radical prostatectomy
Administration of sexual function questionnaire (IIEF-type validated questionnaires)
Time frame: 12 months after the radical prostatectomy
Administration of sexual of life questionnaire (SEAR for self-esteem and couple relationship)
Time frame: 12 months after the radical prostatectomy
Administration of sexual function questionnaire (IIEF-type validated questionnaires)
Time frame: Before the radical prostatectomy
Administration of quality of life questionnaire (EORTC QLC C30 questionnaires)
Time frame: Before the radical prostatectomy
Administration of QLQ-PR25 questionnaire (specific module intended for localized forms of prostate cancer. It is complementary to QLQ-C30 and better suited to measure the side effects of treatment.)
Time frame: 12 Month after the radical prostatectomy
Administration of quality of life questionnaire (EORTC QLC C30 questionnaires)
Time frame: 12 Month after the radical prostatectomy
Administration of QLQ-PR25 questionnaire ((specific module intended for localized forms of prostate cancer. It is complementary to QLQ-C30 and better suited to measure the side effects of treatment.)
University Hospital Center of Martinique
Other
Contributions of a Paramedical Approach in the Prevention and Treatment of Side Effects Associated With Radical Prostatectomy (RP): "Vitality", an Onco-sexology Program
Acronym: VITALITE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03767244
Genital Diseases, Genital Diseases, Male
La Jolla, California, United States
View Trial DetailsNCT04689828
Genital Diseases, Genital Diseases, Male
Denver, Colorado, United States
View Trial DetailsNCT03523442
Genital Diseases, Genital Diseases, Male
Beijing, China
View Trial DetailsNCT02257736
Genital Diseases, Genital Diseases, Male
Phoenix, Arizona, United States
View Trial Details